Glutamate’s Role in Rapidly-Acting Antidepressants

Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its...

Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in...

Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes

Filament Health Shares to Commence Trading on the OTC Market

Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical...

PT261 – Dr. Tiago Reis Marques – Ketamine, New Drugs, and...

Psychedelic Bulletin: DEA Proposes Increase to Psilocybin Quota; Field Trip Launches...

PTSF75 – Possession Limits, Religion, and Scalability

Glow Time: PsychLight Brings a Powerful Tool to Psychedelic Research

Load more